(Q24814874)

5 July 2017

Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment (English)

1 reference

5 July 2017

anti-retroviral agent

0 references

0 references

6

Steven G Deeks

1 reference

5 July 2017

Christos J Petropoulos

5

object named as

Christos J Petropoulos

1 reference

5 July 2017

Serena S Spudich

1

1 reference

5 July 2017

Annelie C Nilsson

2

1 reference

5 July 2017

Nicole D Lollo

3

1 reference

5 July 2017

Teri J Liegler

4

1 reference

5 July 2017

Ellen E Paxinos

7

1 reference

5 July 2017

Richard W Price

8

1 reference

5 July 2017

language of work or name

English

0 references

publication date

2 November 2005

1 reference

5 July 2017

BMC Infectious Diseases

1 reference

5 July 2017

5

1 reference

5 July 2017

1

0 references

page(s)

98

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2334-5-98

5 July 2017

0 references

cites work

The neuropathogenesis of AIDS

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

A long-term latent reservoir for HIV-1: discovery and clinical implications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Neuroprotective therapy for HIV dementia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Clinical implications of HIV-1 drug resistance in the neurological compartment.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Changing incidence of central nervous system diseases in the EuroSIDA cohort

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Comparative neurovirulence in lentiviral infections: The roles of viral molecular diversity and select proteases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

High levels of adherence do not prevent accumulation of HIV drug resistance mutations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Three or more routes for leukocyte migration into the central nervous system

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

HIV-1 persistence, viral reservoir, and the central nervous system in the HAART era.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Pathways to neuronal injury and apoptosis in HIV-associated dementia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

HIV-1-associated central nervous system dysfunction

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Management of AIDS dementia complex and HIV-1 infection of the nervous system.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Evaluation of the AIDS dementia complex in adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Diagnostic lumbar puncture in HIV-infected patients: analysis of 138 cases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Measuring the "viral load" in cerebrospinal fluid in human immunodeficiency virus infection: window into brain infection?

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Human immunodeficiency virus-associated meningitis. Clinical course and correlations

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

The AIDS dementia complex: I. Clinical features

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

Antiretroviral drugs and the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

Cerebrospinal fluid response to structured treatment interruption after virological failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

Human immunodeficiency virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

Two phases of HIV RNA decay in CSF during initial days of multidrug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

Human immunodeficiency virus-related headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-98

The two faces of HIV infection of cerebrospinal fluid

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1299327

Long-term virological effect of highly active antiretroviral therapy on cerebrospinal fluid and relationship with genotypic resistance

28 November 2018

1 reference

12 December 2020

Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals

1 reference

12 December 2020

Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment: a longitudinal study

1 reference

12 December 2020

Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients

1 reference

12 December 2020

Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force

1 reference

12 December 2020

HIV infection and dementia

1 reference

12 December 2020

Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy

1 reference

12 December 2020

Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels

1 reference

12 December 2020

Early HIV-1 infection and the AIDS dementia complex

1 reference

12 December 2020

Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection

1 reference

12 December 2020

Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2334-5-98

1 reference

Dimensions Publication ID

5 July 2017

0 references

1 reference

5 July 2017

1 reference